Skip to content

CorMedix CRMD Contract Assets, Net

Contract Assets, Net at other companies

Merck & Co. logo
Merck & Co.MRK
$72M-14.3%
Abbott logo
AbbottABT
$146M-13.1%

Other financials

Income statement

See full
Revenue$127.4M+226%
Gross profit$115.4M+207%
Operating income$63.7M+216%
Net income$38.6M+87.0%
EPS (diluted)$0.43+43.3%

Balance sheet

See full
Cash & equivalents$179.1M+170%
Total debt$4.3M+729%
Total equity$437.0M+280%
Total assets$815.6M+445%

Cash flow

See full
Operating cash flow$42.4M+115%
CapEx$729.0K+7,190%
Free cash flow$41.7M+111%

Valuation

See full
Market cap$605.65M-34.4%
P/E3.4×
P/S1.5×-9.6×

Profitability

See full
Gross margin91.9%-3.5pp
Operating margin48.4%
Net margin45.2%
FCF margin48.7%+38.8pp

Returns & leverage

See full
Return on equity65.6%
Debt / equity0.0×
Current ratio-1.2×

Where this comes from

Reported directly by CorMedix in its filing.

Tagged under the XBRL concept us-gaap:DeferredTaxAssetsInventory.

The official record: CorMedix’s 10-K, filed March 5, 2026, on SEC EDGAR. View the filing →

Ask your AI about CorMedix's contract assets, net.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is CorMedix's contract assets, net?
CorMedix (CRMD) reported contract assets, net of $256K in Q4 2025.
What does contract assets, net mean?
Contract assets represent the company's right to consideration in exchange for goods or services that have been transferred to a customer, but where the right to payment is conditional on something other than the passage of time. This is reported net of any impairment allowances to reflect the expected realizable value. It serves as a leading indicator of future cash inflows from customer contracts.